Hindustan Times Leadership Summit 2020. Pune-based drug maker signed a deal with British-Swedish company AstraZeneca to manufacture COVID-19 vaccine candidate, developed by the University of Oxford.
The final stage of the clinical trial of Oxford's COVID-19 vaccine has already started in the country.The drugmaker may apply for the emergency authorisation of Oxford COVID-19 vaccine in India.
Then COVID-19 vaccine will be available by December for essential workers, said Poonawalla. However, the decision will depend on the trial result, said the CEO, Serum Institute of India.